Table 2 Rare protein truncating variants in the BROCA gene set

From: Rare germline variants in DNA repair genes and the angiogenesis pathway predispose prostate cancer patients to develop metastatic disease

Gene

dbSNP ID

Variant type

Ref

Alt

Protein change

ClinVar

ExAC MAF (EUR)

CADD

Phenotype category

ATM

 

Frameshift deletion

A

p.K828fs

31

Non-aggressive

ATM

rs587779834

Frameshift deletion

G

p.V1268fs

5

4.5×10−5

28.3

Metastatic

ATM

rs786204751

Nonsense

C

T

p.Q1839*

4

46

Metastatic

ATM

rs770641163

Nonsense

C

T

p.R2993*

5|4

3.0×10−5

47

Metastatic

ATR

 

Nonsense

A

T

p.Y1527*

42

Metastatic

BRCA2

rs41293477

Nonsense

T

G

p.L1053*

5

29.2

Non-aggressive

BRCA2

rs80359454

Frameshift deletion

GAAA

p.E1493fs

5

29.6

Metastatic

BRCA2

rs80359470

Frameshift deletion

AA

p.N1626fs

5

25.5

Metastatic

BRCA2

rs11571658

Frameshift deletion

TT

p.L2092fs

5

1.5×10−5

24.6

Metastatic

BRCA2

rs80359752

Frameshift insertion

A

p.T3085fs

5

36

Metastatic

CHEK2

rs587781269

Nonsense

G

A

p.R95*

5

0

38

Non-aggressive

NBN

rs587780100

Frameshift deletion

TGTT

p.K233fs

5

4.7×10−5

35

Metastatic

NBN

rs587776650

Frameshift deletion

TTTGT

p.K219fs

5

3.2×10−5

35

Metastatic

NBN

 

Frameshift deletion

C

p.R89fs

8.3

Metastatic

NBN

rs587781891

Frameshift deletion

G

p.I41fs

5

28.3

Metastatic

PALB2

rs180177110

Nonsense

G

A

p.R753*

5

4.5×10−5

35

Metastatic

PMS2

 

Nonsense

G

A

p.Q244*

40

Metastatic

PRSS1

rs766199324

Frameshift deletion

C

p.P164fs

1.5×10−5

26

Metastatic

RAD51D

rs786202750

Frameshift deletion

A

p.T188fs

5

27

Metastatic

SLX4

 

Frameshift deletion

C

p.A1653fs

20.5

Non-aggressive

SLX4

rs767631456

Frameshift deletion

CT

p.S936fs

4.5×10−5

24

Metastatic

XRCC2

rs776336749

Frameshift deletion

T

p.H268fs

3

0

28.3

Metastatic

  1. All Tier 1 variants identified for genes in the 60 gene BROCA panel are described, alongside case phenotype status. For each variant, the type of alteration, consequence at the protein level and CADD score are provided. dbSNP identifiers, ClinVar clinical significance score (5 = pathogenic, 4 = likely pathogenic, 3 = uncertain significance) and minor allele frequency in ExAC non-Finnish Europeans are provided for variants present in the respective databases